Cargando…

Ultrasound‐guided femoral nerve block and intravenous fentanyl in pain management of the patients with hip fracture: a prospective, randomized, single blinded clinical trial

AIM: Proximal femoral fracture is a painful condition. Pain alleviation is a treatment cornerstone to both comfort the patient and reduce adverse effects. This study aimed to evaluate and compare ultrasound‐guided femoral nerve block and intravenous fentanyl administration in relieving the pain of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayel, Masoud, Foroughian, Mahdi, Zamani, Nasim, Shahabinejad, Nazanin, Hassanian‐Moghaddam, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623599/
https://www.ncbi.nlm.nih.gov/pubmed/36330310
http://dx.doi.org/10.1002/ams2.804
_version_ 1784822036386807808
author Mayel, Masoud
Foroughian, Mahdi
Zamani, Nasim
Shahabinejad, Nazanin
Hassanian‐Moghaddam, Hossein
author_facet Mayel, Masoud
Foroughian, Mahdi
Zamani, Nasim
Shahabinejad, Nazanin
Hassanian‐Moghaddam, Hossein
author_sort Mayel, Masoud
collection PubMed
description AIM: Proximal femoral fracture is a painful condition. Pain alleviation is a treatment cornerstone to both comfort the patient and reduce adverse effects. This study aimed to evaluate and compare ultrasound‐guided femoral nerve block and intravenous fentanyl administration in relieving the pain of patients with hip fractures. METHODS: The present interventional clinical trial was conducted on 40 patients referred to Shahid‐Bahonar Hospital with unilateral isolated proximal femur fracture and American Society of Anesthesiologists I and II. The patients were randomly divided into two groups: intravenous fentanyl and ultrasound‐guided femoral nerve block for pain management. Pain severity was assessed by a numerical rating scale before and after the intervention in both groups and the groups were then compared. RESULTS: Forty patients were enrolled in to study; 27 (67.5%) were male. There was no significant difference in demographic variables between the two groups. Fourteen (35%) were older than 80 years. Pain significantly decreased three scores compared to the pre‐intervention level in both groups (95% confidence interval, 2–4). This was slightly higher in the femoral nerve block group. The largest strength of association for age and numerical rating scale of pain was found in the differences between the pre‐intervention and after‐intervention in femoral nerve block group (r = −0.775, P < 0.001). CONCLUSION: We found similar pain severity between the two groups. Considering the possible side effects of fentanyl, an ultrasound‐guided femoral nerve block shows may provide safer pain control and may be particularly suitable for patients with opioid dependence.
format Online
Article
Text
id pubmed-9623599
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96235992022-11-02 Ultrasound‐guided femoral nerve block and intravenous fentanyl in pain management of the patients with hip fracture: a prospective, randomized, single blinded clinical trial Mayel, Masoud Foroughian, Mahdi Zamani, Nasim Shahabinejad, Nazanin Hassanian‐Moghaddam, Hossein Acute Med Surg Original Articles AIM: Proximal femoral fracture is a painful condition. Pain alleviation is a treatment cornerstone to both comfort the patient and reduce adverse effects. This study aimed to evaluate and compare ultrasound‐guided femoral nerve block and intravenous fentanyl administration in relieving the pain of patients with hip fractures. METHODS: The present interventional clinical trial was conducted on 40 patients referred to Shahid‐Bahonar Hospital with unilateral isolated proximal femur fracture and American Society of Anesthesiologists I and II. The patients were randomly divided into two groups: intravenous fentanyl and ultrasound‐guided femoral nerve block for pain management. Pain severity was assessed by a numerical rating scale before and after the intervention in both groups and the groups were then compared. RESULTS: Forty patients were enrolled in to study; 27 (67.5%) were male. There was no significant difference in demographic variables between the two groups. Fourteen (35%) were older than 80 years. Pain significantly decreased three scores compared to the pre‐intervention level in both groups (95% confidence interval, 2–4). This was slightly higher in the femoral nerve block group. The largest strength of association for age and numerical rating scale of pain was found in the differences between the pre‐intervention and after‐intervention in femoral nerve block group (r = −0.775, P < 0.001). CONCLUSION: We found similar pain severity between the two groups. Considering the possible side effects of fentanyl, an ultrasound‐guided femoral nerve block shows may provide safer pain control and may be particularly suitable for patients with opioid dependence. John Wiley and Sons Inc. 2022-11-01 /pmc/articles/PMC9623599/ /pubmed/36330310 http://dx.doi.org/10.1002/ams2.804 Text en © 2022 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Mayel, Masoud
Foroughian, Mahdi
Zamani, Nasim
Shahabinejad, Nazanin
Hassanian‐Moghaddam, Hossein
Ultrasound‐guided femoral nerve block and intravenous fentanyl in pain management of the patients with hip fracture: a prospective, randomized, single blinded clinical trial
title Ultrasound‐guided femoral nerve block and intravenous fentanyl in pain management of the patients with hip fracture: a prospective, randomized, single blinded clinical trial
title_full Ultrasound‐guided femoral nerve block and intravenous fentanyl in pain management of the patients with hip fracture: a prospective, randomized, single blinded clinical trial
title_fullStr Ultrasound‐guided femoral nerve block and intravenous fentanyl in pain management of the patients with hip fracture: a prospective, randomized, single blinded clinical trial
title_full_unstemmed Ultrasound‐guided femoral nerve block and intravenous fentanyl in pain management of the patients with hip fracture: a prospective, randomized, single blinded clinical trial
title_short Ultrasound‐guided femoral nerve block and intravenous fentanyl in pain management of the patients with hip fracture: a prospective, randomized, single blinded clinical trial
title_sort ultrasound‐guided femoral nerve block and intravenous fentanyl in pain management of the patients with hip fracture: a prospective, randomized, single blinded clinical trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623599/
https://www.ncbi.nlm.nih.gov/pubmed/36330310
http://dx.doi.org/10.1002/ams2.804
work_keys_str_mv AT mayelmasoud ultrasoundguidedfemoralnerveblockandintravenousfentanylinpainmanagementofthepatientswithhipfractureaprospectiverandomizedsingleblindedclinicaltrial
AT foroughianmahdi ultrasoundguidedfemoralnerveblockandintravenousfentanylinpainmanagementofthepatientswithhipfractureaprospectiverandomizedsingleblindedclinicaltrial
AT zamaninasim ultrasoundguidedfemoralnerveblockandintravenousfentanylinpainmanagementofthepatientswithhipfractureaprospectiverandomizedsingleblindedclinicaltrial
AT shahabinejadnazanin ultrasoundguidedfemoralnerveblockandintravenousfentanylinpainmanagementofthepatientswithhipfractureaprospectiverandomizedsingleblindedclinicaltrial
AT hassanianmoghaddamhossein ultrasoundguidedfemoralnerveblockandintravenousfentanylinpainmanagementofthepatientswithhipfractureaprospectiverandomizedsingleblindedclinicaltrial